心房动:通过节奏和节奏管理,更好地控制症状
Dhiraj Gupta1,2, Michiel Rienstra3, Isabelle C van Gelder3
1Liverpool Heart & Chest Hospital, Thomas Drive, Liverpool, United Kingdom.
The Lancet regional health. Europe
|February 16, 2024
概括
前庭动 (AF) 管理侧重于症状控制,以改善生活质量. 本综述涵盖了AF患者药物和干预措施的证据,例如导管切除以控制AF患者的速率或节律.
科学领域:
- 心脏病学 心脏病学
- 电力生理学 电力生理学
背景情况:
- 心房动 (AF) 显著损害患者的生活质量,因为限制症状.
- 症状控制是管理AF的关键方面之一.
- 有各种药物和干预治疗方法可用于AF管理.
研究的目的:
- 审查目前AF症状控制策略的证据基础.
- 在AF中比较速度与节奏控制的优缺点.
- 为患者提供有关AF治疗方法的使用和咨询的实用指导.
主要方法:
- 对AF治疗现有证据的审查.
- 讨论药理选择 (抗心律失常药物,节律控制药物).
- 评估干预程序 (心脏转移,导管切除,节奏和切除).
主要成果:
- 治疗策略,包括药物和干预措施,可以改善AF患者的生活质量.
- 速度和节奏控制方法都有明显的优点和缺点.
- 导管切除是一种越来越多地用于AF症状管理的干预措施.
结论:
- 综合性AF管理包括针对症状控制的量身定制的治疗策略.
- 临床医生应为患者提供所有可用选择的建议,包括药物和干预措施.
- 优化治疗可以改善心房动患者的生活质量.
相关概念视频
Disturbances in Heart Rhythm
956
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
956
Increased pulse rate
664
Tachycardia is a condition marked by an abnormally fast or irregular heart rate, surpassing the typical resting rate. In adults, tachycardia is characterized by a pulse rate ranging from 100 to 180 beats per minute. The increased heart rate can result in inadequate blood flow to various body parts, ultimately diminishing the oxygen supply to organs and tissues.
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
664
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
832
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
832
Decreased pulse rate
544
Bradycardia is a medical condition in which the heart rate is slower than normal. It occurs when the heart's natural pacemaker, the sinus node, generates slower electrical impulses than the standard rhythm. In adults, bradycardia is diagnosed when the pulse rate falls below 60 beats per minute, indicating a deviation from the normal heart rate range.
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
544
Pulse rhythm
798
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
798
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
744
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
744


